Types of Cancer Codexery

Lung cancer

Lung cancer is the leading cause of cancer death globally.

Lung cancer

Modificado de OpenStax College · CC BY-SA 3.0

Lung cancer is a malignant tumor that originates in the tissues of the lungs, caused by genetic damage to the DNA of cells in the airways, often from cigarette smoking or inhaling damaging chemicals. It is the most diagnosed and deadliest cancer worldwide, with 2.2 million cases in 2020 resulting in 1.8 million deaths, and its incidence and outcomes vary widely depending on patterns of tobacco use.

Quick Facts

Field
Oncology, pulmonology
Symptoms
Coughing (including coughing up blood), shortness of breath, chest pain
Types
Small-cell lung carcinoma (SCLC), non-small-cell lung carcinoma (NSCLC)
Risks
Tobacco smoking · air pollution · asbestos · radon · other environmental mutagens
Diagnosis
Medical imaging, tissue biopsy
Prevention
Avoid smoking and other environmental mutagens
Treatment
Surgery, chemotherapy, radiotherapy, molecular therapies, immune checkpoint inhibitors

Facts from the source article.

Lore & Background

Lung cancer originates in the lung tissues, with damaged airway cells multiplying unchecked to form tumors. Without treatment, tumors spread throughout the lung, damaging function, and eventually metastasize to other parts of the body. Early lung cancer often has no symptoms and can only be detected by medical imaging; as it progresses, most people experience nonspecific respiratory problems such as coughing, shortness of breath, or chest pain. Around 15% of cases are small-cell lung cancer (SCLC), and the remaining 85% are non-small-cell lung cancers (NSCLC), including adenocarcinomas, squamous-cell carcinomas, and large-cell carcinomas.

Reader's Guide

Lung cancer's significance lies in its status as the most diagnosed and deadliest cancer worldwide, with 2.2 million cases and 1.8 million deaths in 2020. Most cases are caused by tobacco smoking, with the remainder from hazardous substances like asbestos and radon gas, or random genetic mutations. Prior to the 20th century, lung cancer was rare; increasing evidence in the 1950s and 1960s linked it to tobacco use, leading to health body declarations discouraging smoking. Prevention efforts focus on avoiding hazardous chemicals and quitting smoking, which reduces risk and improves treatment outcomes. Survival rates are higher in those diagnosed at an earlier stage, at a younger age, and in women compared to men. Even with treatment, only around 20% of people survive five years from diagnosis.

Did You Know?

Cellular Origins and Tumor Progression

Lung cancer begins as a malignant tumor rooted in the tissues of the lungs. At its core, the disease is a story of genetic damage: the DNA within airway cells becomes corrupted, most often through the repeated assault of cigarette smoke or the inhalation of harmful chemicals. Once that damage crosses a critical threshold, the affected cells acquire the ability to divide without restraint, spawning a growing mass of tissue. Left untreated, the tumor expands through the lung, progressively eroding the organ's capacity to function. The final and most dangerous phase is metastasis, in which cancer cells break free and colonize distant organs throughout the body. The entire trajectory—from a single mutated cell to a systemic disease—underscores why early detection remains so vital, and why the window for effective intervention narrows as the tumor gains ground.

Detection, Diagnosis, and Classification

Because early-stage lung cancer typically presents no symptoms whatsoever, it often slips past routine notice and is first caught through medical imaging. As the disease advances, patients commonly report vague respiratory complaints—a new or worsening cough, breathlessness, or a persistent dull chest pain—that are easy to misattribute to other conditions. Suspected cases trigger a cascade of imaging studies designed to map the tumor's location and extent. However, imaging alone cannot confirm the diagnosis; a tissue biopsy must be examined by a pathologist under a microscope. The pathologist not only confirms the presence of malignant cells but also identifies the specific cell type from which the tumor arose. Roughly fifteen percent of cases are classified as small-cell lung cancer, while the remaining eighty-five percent fall under the non-small-cell umbrella, encompassing adenocarcinomas, squamous-cell carcinomas, and large-cell carcinomas. Following this classification, additional imaging and biopsies establish the cancer's stage based on how far it has spread.

Treatment Pathways and Survival Outcomes

The therapeutic approach to lung cancer depends heavily on how far the disease has progressed at the time of diagnosis. For early-stage tumors, surgeons may remove the affected tissue entirely, often followed by radiation therapy and chemotherapy to eliminate any microscopic remnants. When the cancer has advanced to later stages, the strategy shifts toward a combination of radiation, chemotherapy, and targeted drug therapies designed to exploit the specific molecular characteristics of particular cancer subtypes. Despite these tools, the overall prognosis remains sobering: approximately twenty percent of patients survive five years beyond their diagnosis. Survival odds improve meaningfully for those caught at an earlier stage, for younger patients, and for women relative to men. One additional factor carries particular weight—quitting smoking. Cessation not only lowers the probability of developing lung cancer in the first place but also measurably improves treatment outcomes for individuals who have already been diagnosed.

Global Burden and the Tobacco Connection

Lung cancer stands as both the most frequently diagnosed and the deadliest form of cancer worldwide. In 2020 alone, the disease accounted for 2.2 million new cases and 1.8 million deaths. It is exceedingly rare in people under forty; the average age at diagnosis hovers around seventy, and the average age at death reaches seventy-two. Geographic variation in incidence and outcomes tracks closely with local patterns of tobacco consumption. The historical arc is striking: before the widespread adoption of cigarette smoking in the twentieth century, lung cancer was a rarity. By the 1950s and 1960s, mounting scientific evidence had firmly linked tobacco use to the disease, prompting most major national health organizations to issue formal discouragements of smoking. Beyond tobacco, a smaller share of cases stems from exposure to hazardous substances such as asbestos and radon gas, or from spontaneous genetic mutations. Prevention strategies therefore center on avoiding toxic chemicals and, above all, on quitting smoking.

Gallery

Frequently Asked Questions

Who is Lung cancer?

Lung cancer is a malignant growth that develops when genetic damage alters the DNA of cells lining the airways, causing them to multiply uncontrollably within lung tissue. It is the most frequently diagnosed cancer globally, with roughly 2.2 million new cases recorded in 2020.

What are Lung cancer's powers/role?

Its primary 'power' is the ability to hijack normal cell-division signals in the airway lining, producing tumors that can spread to distant organs. The vast majority of cases are linked to tobacco smoking or inhalation of harmful chemicals, which deliver the initial genetic damage that sets the process in motion.

Why is Lung cancer important?

It holds the dual distinction of being both the most diagnosed and the deadliest cancer on the planet, accounting for more deaths than any other single malignancy. Its global burden is heavily shaped by regional patterns of tobacco use, which drive both incidence and patient outcomes.

What's Lung cancer's origin story?

The condition typically begins when cumulative genetic damage—most often from decades of cigarette smoke or toxic chemical exposure—disrupts the DNA of airway cells. The average person is diagnosed around age 70, reflecting the long accumulation period those mutations need before a malignant tumor forms.

More in Types of cancer 1-21

Spotted an error? Know more?

Reader corrections go straight into our review queue. Suggest an edit · How this site is sourced

Comments

Loading…
Open in the interactive codex →